Clinical trial
Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent…
NCT00454142 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00454142 |
|---|---|
| Title | Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer |
| Official title | A Phase 2 Study of GW786034 (Pazopanib) in Asian Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx |
| Intervention type | Drug, Other, Procedure |
| Interventions | pazopanib hydrochloride, pharmacological study, computed tomography |
| Enrollment | 33 |
| Start date | Aug 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Mar 30, 2007 |
| Last update posted | Dec 17, 2015 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: